Jayanth S. Shankara Narayanan

Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model

Jayanth S. Shankara Narayanan, Partha Ray, Tomoko Hayashi et al. · Cancer Immunology Research · 2019 · 113 citations

Life Sciences, Immunology, Oncology +17

Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis

Duygu Ozmadenci, Jayanth S. Shankara Narayanan, Jacob R. Andrew et al. · Proceedings of the National Academy of Sciences · 2022 · 75 citations · Full text

Medicine, Cancer Biology, Oncology +17

Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice

Jayanth S. Shankara Narayanan, Jagat R. Kanwar, Afrah Jalil Abd AL-Juhaishi · Scientific Reports · 2016 · 55 citations · Full text

Medicine, Oncology, Pharmacology +14

Identification of Unprecedented Anticancer Properties of High Molecular Weight Biomacromolecular Complex Containing Bovine Lactoferrin (HMW-bLf)

Fawzi Ebrahim, Jayanth S. Shankara Narayanan, Jagat R. Kanwar et al. · PLoS ONE · 2014 · 40 citations · Full text

Medicine, Biochemistry, Oncology +14

Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model

Jayanth S. Shankara Narayanan, Tomoko Hayashi, Suna Erdem et al. · Journal for ImmunoTherapy of Cancer · 2023 · 39 citations · Full text

Life Sciences, Immunology, Oncology +17